Nicholas T. Perry

492 total citations · 1 hit paper
10 papers, 263 citations indexed

About

Nicholas T. Perry is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, Nicholas T. Perry has authored 10 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Plant Science and 2 papers in Pharmacology. Recurrent topics in Nicholas T. Perry's work include CRISPR and Genetic Engineering (5 papers), RNA and protein synthesis mechanisms (4 papers) and Chromosomal and Genetic Variations (3 papers). Nicholas T. Perry is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), RNA and protein synthesis mechanisms (4 papers) and Chromosomal and Genetic Variations (3 papers). Nicholas T. Perry collaborates with scholars based in United States, Japan and Spain. Nicholas T. Perry's co-authors include Patrick D. Hsu, Matthew G. Durrant, Silvana Konermann, Masahiro Hiraizumi, Hiroshi Nishimasu, Sita S. Chandrasekaran, Peter P. Du, Julia M. Schaepe, Peter Lotfy and Josh Tycko and has published in prestigious journals such as Nature, Science and Nature Biotechnology.

In The Last Decade

Nicholas T. Perry

10 papers receiving 260 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bridge RNAs direct programmable recombination of target and donor DNA

2024 67 citations Matthew G. Durrant, Nicholas T. Perry et al. Nature profile →

Peers

Nicholas T. Perry

MB

GENET

PS

PHARM

ONCOL

Christine R. Zheng United States

Peter Orchard United States

Alex A. Javanpour United States

Conor J. McClune United States

Julia M. Schaepe United States

Elon Yariv Israel

Martha L. Bulyk United States

Jinjin Tong China

Vimbai M. Chikwana United States

Christine R. Zheng United States

Nicholas T. Perry

261 ×1.2

MB

71 ×1.1

GENET

28 ×0.8

PS

12 ×0.9

PHARM

6 ×0.5

ONCOL

Citations per year, relative to Nicholas T. Perry Nicholas T. Perry (= 1×) peers Christine R. Zheng

Countries citing papers authored by Nicholas T. Perry

Since Specialization

Citations

This map shows the geographic impact of Nicholas T. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas T. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas T. Perry more than expected).

Fields of papers citing papers by Nicholas T. Perry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas T. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas T. Perry. The network helps show where Nicholas T. Perry may publish in the future.

Co-authorship network of co-authors of Nicholas T. Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas T. Perry. A scholar is included among the top collaborators of Nicholas T. Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas T. Perry. Nicholas T. Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Perry, Nicholas T., Dhruva Katrekar, Matthew G. Durrant, et al.. (2025). Megabase-scale human genome rearrangement with programmable bridge recombinases. Science. 391(6790). eadz0276–eadz0276. 5 indexed citations

2.

Hiraizumi, Masahiro, Nicholas T. Perry, Matthew G. Durrant, et al.. (2024). Structural mechanism of bridge RNA-guided recombination. Nature. 630(8018). 994–1002. 31 indexed citations

3.

Durrant, Matthew G., Nicholas T. Perry, Aditya R. Jangid, et al.. (2024). Bridge RNAs direct programmable recombination of target and donor DNA. Nature. 630(8018). 984–993. 67 indexed citations breakdown →

4.

Durrant, Matthew G., Alison Fanton, Josh Tycko, et al.. (2022). Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genome. Nature Biotechnology. 41(4). 488–499. 102 indexed citations

5.

Tak, Y. Esther, Gaylor Boulay, Sowmya Iyer, et al.. (2022). Genome-wide functional perturbation of human microsatellite repeats using engineered zinc finger transcription factors. Cell Genomics. 2(4). 100119–100119. 7 indexed citations

6.

Tak, Y. Esther, Joy E. Horng, Nicholas T. Perry, et al.. (2021). Augmenting and directing long-range CRISPR-mediated activation in human cells. Nature Methods. 18(9). 1075–1081. 19 indexed citations

7.

Malamas, Michael S., Spiro Pavlopoulos, Shakiru O. Alapafuja, et al.. (2021). Design and Structure–Activity Relationships of Isothiocyanates as Potent and Selective N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibitors. Journal of Medicinal Chemistry. 64(9). 5956–5972. 3 indexed citations

8.

Perry, Nicholas T., Kevin Wasko, Jason X. Cheng, et al.. (2020). Methylation-Sensitive Restriction Enzyme Quantitative Polymerase Chain Reaction Enables Rapid, Accurate, and Precise Detection of Methylation Status of the Regulatory T Cell (Treg)-Specific Demethylation Region in Primary Human Tregs. The Journal of Immunology. 206(2). 446–451. 6 indexed citations

9.

Valle, Adamo, Nicholas T. Perry, Ester Kalef-Ezra, et al.. (2020). HMTase Inhibitors as a Potential Epigenetic-Based Therapeutic Approach for Friedreich’s Ataxia. Frontiers in Genetics. 11. 584–584. 6 indexed citations

10.

Malamas, Michael S., Manjunath Lamani, Nicholas T. Perry, et al.. (2019). Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors. Bioorganic & Medicinal Chemistry. 28(1). 115195–115195. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact